speb/financial-data huggingface dataset:
UTI balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 0.00
UTI cash_flow (annual, 2024-09-30) — Preferred Stock Dividend Paid: -1097000.00
UTI cash_flow (quarterly, 2024-09-30) — Preferred Stock Dividend Paid: 0.00
UTI income_statement (annual, 2024-09-30) — Preferred Stock Dividends: 1097000.00
UTI income_statement (quarterly, 2024-09-30) — Preferred Stock Dividends: 0.00
UTI cash_flow (annual, 2024-09-30) — Preferred Stock Payments: -11503000.00
UTI cash_flow (quarterly, 2024-09-30) — Preferred Stock Payments: 0.00
UTI balance_sheet (annual, 2024-09-30) — Prepaid Assets: 11945000.00
UTI income_statement (annual, 2024-09-30) — Pretax Income: 56230000.00
UTI cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (annual, 2024-09-30) — Properties: 0.00
UTI cash_flow (annual, 2024-09-30) — Provisionand Write Offof Assets: 7547000.00
UTI cash_flow (annual, 2024-09-30) — Purchase Of Business: 0.00
UTI cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
UTI cash_flow (annual, 2024-09-30) — Purchase Of Investment: 0.00
UTI cash_flow (annual, 2024-09-30) — Purchase Of PPE: -24298000.00
UTI balance_sheet (annual, 2024-09-30) — Receivables: 37296000.00
UTI balance_sheet (annual, 2024-09-30) — Receivables Adjustments Allowances: -10376000.00
UTI balance_sheet (quarterly, 2024-09-30) — Receivables Adjustments Allowances: -10376000.00
UTI income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 384529000.00
UTI income_statement (annual, 2024-09-30) — Reconciled Depreciation: 51185000.00
UTI income_statement (annual, 2024-09-30) — Rent Expense Supplemental: 52366000.00
UTI cash_flow (annual, 2024-09-30) — Repayment Of Debt: -77518000.00
UTI cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: -11503000.00
UTI cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (annual, 2024-09-30) — Restricted Cash: 5572000.00
UTI balance_sheet (annual, 2024-09-30) — Retained Earnings: 38509000.00
UTI income_statement (annual, 2024-09-30) — Salaries And Wages: 147702000.00
UTI cash_flow (annual, 2024-09-30) — Sale Of Business: 0.00
UTI cash_flow (annual, 2024-09-30) — Sale Of Investment: 0.00
UTI income_statement (annual, 2024-09-30) — Selling And Marketing Expense: 78261000.00
UTI income_statement (annual, 2024-09-30) — Selling General And Administration: 289267000.00
UTI balance_sheet (annual, 2024-09-30) — Share Issued: 53898995.00
UTI cash_flow (annual, 2024-09-30) — Short Term Debt Issuance: 41000000.00
UTI cash_flow (annual, 2024-09-30) — Stock Based Compensation: 8560000.00
UTI balance_sheet (annual, 2024-09-30) — Stockholders Equity: 260231000.00
UTI balance_sheet (annual, 2024-09-30) — Tangible Book Value: 213543000.00
UTI income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (annual, 2024-09-30) — Tax Provision: 14229000.00
UTI income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.25
UTI balance_sheet (annual, 2024-09-30) — Taxes Receivable: 2333000.00
UTI balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 2333000.00
UTI balance_sheet (annual, 2024-09-30) — Total Assets: 744575000.00
UTI balance_sheet (annual, 2024-09-30) — Total Capitalization: 383238000.00
UTI balance_sheet (annual, 2024-09-30) — Total Debt: 294745000.00
UTI balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 260231000.00
UTI income_statement (annual, 2024-09-30) — Total Expenses: 673796000.00
UTI balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 484344000.00
UTI balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 522624000.00
UTI balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 279381000.00
UTI income_statement (annual, 2024-09-30) — Total Operating Income As Reported: 58891000.00
UTI balance_sheet (annual, 2024-09-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (annual, 2024-09-30) — Treasury Stock: 365000.00
UTI balance_sheet (annual, 2024-09-30) — Working Capital: 16988000.00
UTI cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -3752000.00
UTI cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -2063000.00
UTI cash_flow (quarterly, 2024-12-31) — Change In Payable: -3752000.00
UTI cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
UTI income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
UTI balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Preferred Stock Dividend Paid: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Preferred Stock Payments: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 2101000.00
UTI cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
UTI cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
UTI income_statement (quarterly, 2025-03-31) — +Operating Expense: 88106000.00
UTI income_statement (quarterly, 2025-03-31) — +Total Revenue: 207447000.00
UTI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 19823000.00
UTI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 31240000.00
UTI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -214365000.00
UTI balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 220900000.00
UTI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 54383000.00
UTI income_statement (quarterly, 2025-03-31) — Basic EPS: 0.21
UTI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 177754000.00
UTI balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 166202000.00
UTI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -10947000.00
UTI cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 162513000.00
UTI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 5000.00
UTI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 95998000.00
UTI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 135689000.00
UTI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
UTI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -25814000.00
UTI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -50638000.00
UTI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -789000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1367000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -6390000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -15956000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 459000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2104000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -11150000.00
UTI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -36508000.00
UTI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -77241000.00
UTI balance_sheet (quarterly, 2025-03-31) — Common Stock: 5000.00
UTI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 293913000.00
UTI balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 10602000.00
UTI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 102488000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 25805000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Assets: 198452000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 21927000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Debt: 2779000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 24706000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 74943000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 74943000.00
UTI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 185100000.00
UTI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 195000.00
UTI cash_flow (quarterly, 2025-03-31) — Deferred Tax: 195000.00
UTI cash_flow (quarterly, 2025-03-31) — Depreciation: 13861000.00
UTI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 13861000.00
UTI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 13861000.00
UTI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 55442000.00
UTI income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.21
UTI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — EBIT: 18491000.00
UTI income_statement (quarterly, 2025-03-31) — EBITDA: 32352000.00
UTI cash_flow (quarterly, 2025-03-31) — End Cash Position: 100513000.00
UTI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -25814000.00
UTI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -11736000.00
UTI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -386000.00
UTI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1265000.00
UTI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 64152000.00
UTI balance_sheet (quarterly, 2025-03-31) — Goodwill: 28459000.00
UTI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 46241000.00
UTI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 630199000.00
UTI income_statement (quarterly, 2025-03-31) — Gross Profit: 104959000.00
UTI cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 7628000.00
UTI income_statement (quarterly, 2025-03-31) — Interest Expense: 1657000.00
UTI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1657000.00
UTI income_statement (quarterly, 2025-03-31) — Interest Income: 1629000.00
UTI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1629000.00
UTI cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 1756000.00
UTI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 388334000.00
UTI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -50638000.00
UTI cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 25601000.00
UTI balance_sheet (quarterly, 2025-03-31) — Leases: 95424000.00
UTI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 140586000.00
UTI balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 91642000.00
UTI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 232228000.00
UTI cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -25667000.00
UTI balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 51851000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 11446000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 11446000.00
UTI income_statement (quarterly, 2025-03-31) — Net Interest Income: -28000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -39691000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -25667000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -25667000.00
UTI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -28000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -147000.00
UTI balance_sheet (quarterly, 2025-03-31) — Net PPE: 415834000.00
UTI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -10947000.00
UTI cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -30000000.00
UTI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 247672000.00
UTI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 4091000.00
UTI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4696000.00
UTI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 4091000.00
UTI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4696000.00
UTI balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 39972000.00
UTI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 32352000.00
UTI income_statement (quarterly, 2025-03-31) — Normalized Income: 11446000.00
UTI balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 6334000.00
UTI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -789000.00
UTI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -386000.00
UTI income_statement (quarterly, 2025-03-31) — Operating Income: 16853000.00
UTI income_statement (quarterly, 2025-03-31) — Operating Revenue: 207447000.00
UTI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 54406215.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 6616000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 2779000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 5694000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1265000.00
UTI income_statement (quarterly, 2025-03-31) — Other Gand A: 21646000.00
UTI income_statement (quarterly, 2025-03-31) — Other Income Expense: 9000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 17782000.00
UTI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 126000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 15853000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4506000.00
UTI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 9000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Properties: 280519000.00
UTI balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 39691000.00
UTI income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Payables: 19823000.00
UTI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 45628000.00
UTI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 34129000.00
UTI balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
UTI cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: 0.00
UTI cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 14058000.00
UTI income_statement (quarterly, 2025-03-31) — Pretax Income: 16834000.00
UTI cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
UTI cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -39691000.00
UTI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -10947000.00
UTI balance_sheet (quarterly, 2025-03-31) — Receivables: 37574000.00
UTI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 102488000.00
UTI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 13861000.00
UTI income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 13208000.00
UTI cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -25667000.00
UTI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4515000.00
UTI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 72108000.00
UTI income_statement (quarterly, 2025-03-31) — Salaries And Wages: 42506000.00
UTI cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
UTI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 23954000.00
UTI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 88106000.00
UTI balance_sheet (quarterly, 2025-03-31) — Share Issued: 54488215.00
UTI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3024000.00
UTI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 293913000.00
UTI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 247672000.00
UTI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (quarterly, 2025-03-31) — Tax Provision: 5388000.00
UTI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
UTI balance_sheet (quarterly, 2025-03-31) — Total Assets: 720443000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 385555000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Debt: 256934000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 293913000.00
UTI income_statement (quarterly, 2025-03-31) — Total Expenses: 190594000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 426530000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 521991000.00
UTI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 241430000.00
UTI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 16853000.00
UTI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 82000.00
UTI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 365000.00
UTI balance_sheet (quarterly, 2025-03-31) — Working Capital: 13352000.00
UTI income_statement (quarterly, 2025-06-30) — +Operating Expense: 84542000.00
UTI income_statement (quarterly, 2025-06-30) — +Total Revenue: 204298000.00
UTI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 22840000.00
UTI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 37206000.00
UTI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -199519000.00
UTI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 223362000.00
UTI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 54412000.00
UTI income_statement (quarterly, 2025-06-30) — Basic EPS: 0.20
UTI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 100513000.00
UTI balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 167097000.00
UTI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -11207000.00
UTI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 187241000.00
UTI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5000.00
UTI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 70672000.00
UTI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 117834000.00
UTI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
UTI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -20877000.00
UTI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -24290000.00
UTI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 18053000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1953000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -5636000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -8176000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 9748000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -230000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Receivables: -10849000.00
UTI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -17096000.00
UTI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -10637000.00
UTI cash_flow (quarterly, 2025-06-30) — Changes In Cash: -27114000.00
UTI balance_sheet (quarterly, 2025-06-30) — Common Stock: 5000.00
UTI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 306787000.00
UTI balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 16234000.00
UTI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 105604000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 23040000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Assets: 185180000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 18733000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Debt: 2822000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 21555000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 67043000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 67043000.00
UTI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 185025000.00
UTI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 1055000.00
UTI cash_flow (quarterly, 2025-06-30) — Deferred Tax: 1055000.00
UTI cash_flow (quarterly, 2025-06-30) — Depreciation: 14491000.00
UTI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 14491000.00
UTI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 14491000.00
UTI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 55635000.00
UTI income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.19
UTI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — EBIT: 15746000.00
UTI income_statement (quarterly, 2025-06-30) — EBITDA: 30237000.00
UTI cash_flow (quarterly, 2025-06-30) — End Cash Position: 73399000.00
UTI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -20877000.00
UTI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 6846000.00
UTI cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -251000.00
UTI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1014000.00
UTI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 61847000.00
UTI balance_sheet (quarterly, 2025-06-30) — Goodwill: 28459000.00
UTI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 46026000.00
UTI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 642618000.00
UTI income_statement (quarterly, 2025-06-30) — Gross Profit: 98694000.00
UTI cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2712000.00
UTI income_statement (quarterly, 2025-06-30) — Interest Expense: 1394000.00
UTI income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1394000.00
UTI income_statement (quarterly, 2025-06-30) — Interest Income: 1445000.00
UTI income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1445000.00
UTI cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1448000.00
UTI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 380551000.00
UTI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -24290000.00
UTI cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 6000000.00
UTI balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 25601000.00
UTI balance_sheet (quarterly, 2025-06-30) — Leases: 98180000.00
UTI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 168508000.00
UTI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 70942000.00
UTI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 239450000.00
UTI cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 6000000.00
UTI cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -26681000.00
UTI balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 50620000.00
UTI balance_sheet (quarterly, 2025-06-30) — Net Debt: 3092000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 10663000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 10663000.00
UTI income_statement (quarterly, 2025-06-30) — Net Interest Income: 51000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -13083000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -20681000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -20681000.00
UTI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 51000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -196000.00
UTI balance_sheet (quarterly, 2025-06-30) — Net PPE: 443099000.00
UTI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -11207000.00
UTI cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 0.00
UTI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 260761000.00
UTI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2953000.00
UTI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 4696000.00
UTI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 2953000.00
UTI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 4696000.00
UTI balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 40014000.00
UTI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 30237000.00
UTI income_statement (quarterly, 2025-06-30) — Normalized Income: 10663000.00
UTI balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 6504000.00
UTI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 18053000.00
UTI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -251000.00
UTI income_statement (quarterly, 2025-06-30) — Operating Income: 14152000.00
UTI income_statement (quarterly, 2025-06-30) — Operating Revenue: 204298000.00
UTI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 54423611.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 6962000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2822000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 5149000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1014000.00
UTI income_statement (quarterly, 2025-06-30) — Other Gand A: 21410000.00
UTI income_statement (quarterly, 2025-06-30) — Other Income Expense: 149000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 17567000.00
UTI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1024000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 23487000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4801000.00
UTI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 149000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Properties: 284886000.00
UTI balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 47162000.00
UTI income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
UTI balance_sheet (quarterly, 2025-06-30) — Payables: 22840000.00
UTI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 45880000.00
UTI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 45398000.00
UTI cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: 0.00
UTI cash_flow (quarterly, 2025-06-30) — Preferred Stock Payments: 0.00
UTI balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 13947000.00
UTI income_statement (quarterly, 2025-06-30) — Pretax Income: 14352000.00
UTI cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
UTI balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
UTI cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -14957000.00
UTI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -11207000.00
UTI balance_sheet (quarterly, 2025-06-30) — Receivables: 43710000.00
UTI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 105604000.00
UTI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 14491000.00
UTI income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 14399000.00
UTI cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -26681000.00
UTI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
UTI balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 2727000.00
UTI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 82771000.00
UTI income_statement (quarterly, 2025-06-30) — Salaries And Wages: 40437000.00
UTI cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1874000.00
UTI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 22695000.00
UTI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 84542000.00
UTI balance_sheet (quarterly, 2025-06-30) — Share Issued: 54505611.00
UTI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2658000.00
UTI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 306787000.00
UTI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 260761000.00
UTI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
UTI income_statement (quarterly, 2025-06-30) — Tax Provision: 3689000.00
UTI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
UTI balance_sheet (quarterly, 2025-06-30) — Total Assets: 740759000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 377729000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Debt: 261005000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 306787000.00
UTI income_statement (quarterly, 2025-06-30) — Total Expenses: 190146000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 433972000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 555579000.00
UTI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 248947000.00
UTI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 14152000.00
UTI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 82000.00
UTI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 365000.00
UTI balance_sheet (quarterly, 2025-06-30) — Working Capital: 155000.00
UTI income_statement (annual, 2025-09-30) — +Operating Expense: 331656000.00
UTI income_statement (quarterly, 2025-09-30) — +Operating Expense: 85198000.00
UTI income_statement (annual, 2025-09-30) — +Total Revenue: 835616000.00
UTI income_statement (quarterly, 2025-09-30) — +Total Revenue: 222442000.00
UTI balance_sheet (annual, 2025-09-30) — Accounts Payable: 39115000.00
UTI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 39115000.00
UTI balance_sheet (annual, 2025-09-30) — Accounts Receivable: 62588000.00
UTI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 62588000.00
UTI balance_sheet (annual, 2025-09-30) — Accumulated Depreciation: -206257000.00
UTI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -206257000.00
UTI balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 226031000.00
UTI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 226031000.00
UTI income_statement (annual, 2025-09-30) — Basic Average Shares: 54301000.00
UTI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 54425000.00
UTI income_statement (annual, 2025-09-30) — Basic EPS: 1.16
UTI income_statement (quarterly, 2025-09-30) — Basic EPS: 0.34
UTI cash_flow (annual, 2025-09-30) — Beginning Cash Position: 167472000.00
UTI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 73399000.00
UTI balance_sheet (annual, 2025-09-30) — Buildings And Improvements: 167977000.00
UTI balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 167977000.00
UTI cash_flow (annual, 2025-09-30) — Capital Expenditure: -41978000.00
UTI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16479000.00
UTI balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 191805000.00
UTI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 191805000.00
UTI balance_sheet (annual, 2025-09-30) — Capital Stock: 5000.00
UTI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5000.00
UTI balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 127361000.00
UTI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 127361000.00
UTI balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 169145000.00
UTI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 169145000.00
UTI cash_flow (annual, 2025-09-30) — Cash Dividends Paid: 0.00
UTI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
UTI cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: -42793000.00
UTI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 13233000.00
UTI cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -87879000.00
UTI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -9606000.00
UTI cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: 97330000.00
UTI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 57104000.00
UTI cash_flow (annual, 2025-09-30) — Change In Other Current Liabilities: -23269000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -5536000.00
UTI cash_flow (annual, 2025-09-30) — Change In Other Working Capital: 3628000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 25525000.00
UTI cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 11164000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4709000.00
UTI cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -1724000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 2775000.00
UTI cash_flow (annual, 2025-09-30) — Change In Receivables: -43951000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -18005000.00
UTI cash_flow (annual, 2025-09-30) — Change In Working Capital: -54152000.00
UTI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 14851000.00
UTI cash_flow (annual, 2025-09-30) — Changes In Account Receivables: -38711000.00
UTI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -16816000.00
UTI cash_flow (annual, 2025-09-30) — Changes In Cash: -33342000.00
UTI cash_flow (quarterly, 2025-09-30) — Changes In Cash: 60731000.00
UTI balance_sheet (annual, 2025-09-30) — Common Stock: 5000.00
UTI balance_sheet (quarterly, 2025-09-30) — Common Stock: 5000.00
UTI balance_sheet (annual, 2025-09-30) — Common Stock Equity: 328110000.00
UTI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 328110000.00
UTI balance_sheet (annual, 2025-09-30) — Construction In Progress: 32729000.00
UTI balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 32729000.00
UTI income_statement (annual, 2025-09-30) — Cost Of Revenue: 420491000.00
UTI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 112258000.00
UTI balance_sheet (annual, 2025-09-30) — Current Accrued Expenses: 21529000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 21529000.00
UTI balance_sheet (annual, 2025-09-30) — Current Assets: 246632000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Assets: 246632000.00
UTI balance_sheet (annual, 2025-09-30) — Current Capital Lease Obligation: 16967000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 16967000.00
UTI balance_sheet (annual, 2025-09-30) — Current Debt: 2865000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Debt: 2865000.00
UTI balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 19832000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 19832000.00
UTI balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 91525000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 91525000.00
UTI balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 91525000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 91525000.00
UTI balance_sheet (annual, 2025-09-30) — Current Liabilities: 229671000.00
UTI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 229671000.00
UTI cash_flow (annual, 2025-09-30) — Deferred Income Tax: -1337000.00
UTI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1916000.00
UTI cash_flow (annual, 2025-09-30) — Deferred Tax: -1337000.00
UTI cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1916000.00
UTI cash_flow (annual, 2025-09-30) — Depreciation: 56785000.00
UTI cash_flow (quarterly, 2025-09-30) — Depreciation: 14841000.00
UTI cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 56785000.00
UTI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 14841000.00
UTI cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 56785000.00
UTI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 14841000.00
UTI income_statement (annual, 2025-09-30) — Diluted Average Shares: 55615000.00
UTI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 55728000.00
UTI income_statement (annual, 2025-09-30) — Diluted EPS: 1.13
UTI income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.34
UTI income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 18756000.00
UTI income_statement (annual, 2025-09-30) — EBIT: 89907000.00
UTI income_statement (quarterly, 2025-09-30) — EBIT: 26468000.00
UTI income_statement (annual, 2025-09-30) — EBITDA: 146692000.00
UTI income_statement (quarterly, 2025-09-30) — EBITDA: 41309000.00
UTI cash_flow (annual, 2025-09-30) — End Cash Position: 134130000.00
UTI cash_flow (quarterly, 2025-09-30) — End Cash Position: 134130000.00
UTI cash_flow (annual, 2025-09-30) — Financing Cash Flow: -42793000.00
UTI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 13233000.00
UTI cash_flow (annual, 2025-09-30) — Free Cash Flow: 55352000.00
UTI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 40625000.00
UTI cash_flow (annual, 2025-09-30) — Gain Loss On Investment Securities: -194000.00
UTI cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -102000.00
UTI balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 912000.00
UTI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 912000.00
UTI income_statement (annual, 2025-09-30) — General And Administrative Expense: 243066000.00
UTI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 64486000.00
UTI balance_sheet (annual, 2025-09-30) — Goodwill: 28459000.00
UTI balance_sheet (quarterly, 2025-09-30) — Goodwill: 28459000.00
UTI balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 45811000.00
UTI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 45811000.00
UTI balance_sheet (annual, 2025-09-30) — Gross PPE: 670970000.00
UTI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 670970000.00
UTI income_statement (annual, 2025-09-30) — Gross Profit: 415125000.00
UTI income_statement (quarterly, 2025-09-30) — Gross Profit: 110184000.00
UTI cash_flow (annual, 2025-09-30) — Income Tax Paid Supplemental Data: 11255000.00
UTI cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 891000.00
UTI income_statement (annual, 2025-09-30) — Interest Expense: 5633000.00
UTI income_statement (quarterly, 2025-09-30) — Interest Expense: 909000.00
UTI income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 5633000.00
UTI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 909000.00
UTI income_statement (annual, 2025-09-30) — Interest Income: 6173000.00
UTI income_statement (quarterly, 2025-09-30) — Interest Income: 1340000.00
UTI income_statement (annual, 2025-09-30) — Interest Income Non Operating: 6173000.00
UTI income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1340000.00
UTI cash_flow (annual, 2025-09-30) — Interest Paid Supplemental Data: 5908000.00
UTI cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 962000.00
UTI balance_sheet (annual, 2025-09-30) — Invested Capital: 415209000.00
UTI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 415209000.00
UTI cash_flow (annual, 2025-09-30) — Investing Cash Flow: -87879000.00
UTI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -9606000.00
UTI cash_flow (annual, 2025-09-30) — Issuance Of Debt: 26000000.00
UTI cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 20000000.00
UTI balance_sheet (annual, 2025-09-30) — Land And Improvements: 25601000.00
UTI balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 25601000.00
UTI balance_sheet (annual, 2025-09-30) — Leases: 101002000.00
UTI balance_sheet (quarterly, 2025-09-30) — Leases: 101002000.00
UTI balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 174838000.00
UTI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 174838000.00
UTI balance_sheet (annual, 2025-09-30) — Long Term Debt: 84234000.00
UTI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 84234000.00
UTI balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 259072000.00
UTI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 259072000.00
UTI cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -64697000.00
UTI cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -6687000.00
UTI balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 51667000.00
UTI balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 51667000.00
UTI cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: 0.00
UTI income_statement (annual, 2025-09-30) — Net Income: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Income Common Stockholders: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Income Continuous Operations: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 18756000.00
UTI cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: 63018000.00
UTI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 18756000.00
UTI income_statement (annual, 2025-09-30) — Net Interest Income: 540000.00
UTI income_statement (quarterly, 2025-09-30) — Net Interest Income: 431000.00
UTI cash_flow (annual, 2025-09-30) — Net Investment Purchase And Sale: -46070000.00
UTI cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6704000.00
UTI cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: -38697000.00
UTI cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 13313000.00
UTI cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: -64697000.00
UTI cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -12687000.00
UTI income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: 540000.00
UTI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 431000.00
UTI cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -4755000.00
UTI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -80000.00
UTI cash_flow (annual, 2025-09-30) — Net Other Investing Changes: 169000.00
UTI balance_sheet (annual, 2025-09-30) — Net PPE: 464713000.00
UTI balance_sheet (quarterly, 2025-09-30) — Net PPE: 464713000.00
UTI cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -41978000.00
UTI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -16479000.00
UTI cash_flow (annual, 2025-09-30) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
UTI cash_flow (annual, 2025-09-30) — Net Short Term Debt Issuance: 26000000.00
UTI balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 282299000.00
UTI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 282299000.00
UTI balance_sheet (annual, 2025-09-30) — Non Current Deferred Assets: 4283000.00
UTI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 4283000.00
UTI balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 4144000.00
UTI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 4144000.00
UTI balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Assets: 4283000.00
UTI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 4283000.00
UTI balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Liabilities: 4144000.00
UTI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 4144000.00
UTI balance_sheet (annual, 2025-09-30) — Non Current Note Receivables: 41109000.00
UTI balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 41109000.00
UTI income_statement (annual, 2025-09-30) — Normalized EBITDA: 146692000.00
UTI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 41309000.00
UTI income_statement (annual, 2025-09-30) — Normalized Income: 63018000.00
UTI income_statement (quarterly, 2025-09-30) — Normalized Income: 18756000.00
UTI balance_sheet (annual, 2025-09-30) — Notes Receivable: 6597000.00
UTI balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 6597000.00
UTI cash_flow (annual, 2025-09-30) — Operating Cash Flow: 97330000.00
UTI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 57104000.00
UTI cash_flow (annual, 2025-09-30) — Operating Gains Losses: -194000.00
UTI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -102000.00
UTI income_statement (annual, 2025-09-30) — Operating Income: 83469000.00
UTI income_statement (quarterly, 2025-09-30) — Operating Income: 24986000.00
UTI income_statement (annual, 2025-09-30) — Operating Revenue: 835616000.00
UTI income_statement (quarterly, 2025-09-30) — Operating Revenue: 222442000.00
UTI balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 54430000.00
UTI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 54430000.00
UTI balance_sheet (annual, 2025-09-30) — Other Current Assets: 5517000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5517000.00
UTI balance_sheet (annual, 2025-09-30) — Other Current Borrowings: 2865000.00
UTI balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 2865000.00